Global AI Drug Development Platform Supply, Demand and Key Producers, 2023-2029
The global AI Drug Development Platform market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global AI Drug Development Platform demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI Drug Development Platform, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI Drug Development Platform that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI Drug Development Platform total market, 2018-2029, (USD Million)
Global AI Drug Development Platform total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: AI Drug Development Platform total market, key domestic companies and share, (USD Million)
Global AI Drug Development Platform revenue by player and market share 2018-2023, (USD Million)
Global AI Drug Development Platform total market by Type, CAGR, 2018-2029, (USD Million)
Global AI Drug Development Platform total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global AI Drug Development Platform market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Insilico Medicine, MindRank, BenevolentAI, Exscientia, Deep Pharma Intelligence, Delta4, DNDi, Standigm and Genesis Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World AI Drug Development Platform market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global AI Drug Development Platform Market, By Region:
1. How big is the global AI Drug Development Platform market?
2. What is the demand of the global AI Drug Development Platform market?
3. What is the year over year growth of the global AI Drug Development Platform market?
4. What is the total value of the global AI Drug Development Platform market?
5. Who are the major players in the global AI Drug Development Platform market?
6. What are the growth factors driving the market demand?
This report studies the global AI Drug Development Platform demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI Drug Development Platform, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI Drug Development Platform that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI Drug Development Platform total market, 2018-2029, (USD Million)
Global AI Drug Development Platform total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: AI Drug Development Platform total market, key domestic companies and share, (USD Million)
Global AI Drug Development Platform revenue by player and market share 2018-2023, (USD Million)
Global AI Drug Development Platform total market by Type, CAGR, 2018-2029, (USD Million)
Global AI Drug Development Platform total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global AI Drug Development Platform market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Insilico Medicine, MindRank, BenevolentAI, Exscientia, Deep Pharma Intelligence, Delta4, DNDi, Standigm and Genesis Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World AI Drug Development Platform market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global AI Drug Development Platform Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Software Provider Mode
- CRO Service Mode
- Self-Development Pipeline Mode
- SMEs
- Large Enterprises
- Insilico Medicine
- MindRank
- BenevolentAI
- Exscientia
- Deep Pharma Intelligence
- Delta4
- DNDi
- Standigm
- Genesis Therapeutics
- Data2Discovery
- Unlearn.AI
- Deep Intelligent Pharma
- CarbonSilicon AI Technology
- XtalPi
- Tencent
- Fastone
- Stonewise
- HitGen
- Galixir
- Matwings Technology
- Alibaba
1. How big is the global AI Drug Development Platform market?
2. What is the demand of the global AI Drug Development Platform market?
3. What is the year over year growth of the global AI Drug Development Platform market?
4. What is the total value of the global AI Drug Development Platform market?
5. Who are the major players in the global AI Drug Development Platform market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 AI Drug Development Platform Introduction
1.2 World AI Drug Development Platform Market Size & Forecast (2018 & 2022 & 2029)
1.3 World AI Drug Development Platform Total Market by Region (by Headquarter Location)
1.3.1 World AI Drug Development Platform Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States AI Drug Development Platform Market Size (2018-2029)
1.3.3 China AI Drug Development Platform Market Size (2018-2029)
1.3.4 Europe AI Drug Development Platform Market Size (2018-2029)
1.3.5 Japan AI Drug Development Platform Market Size (2018-2029)
1.3.6 South Korea AI Drug Development Platform Market Size (2018-2029)
1.3.7 ASEAN AI Drug Development Platform Market Size (2018-2029)
1.3.8 India AI Drug Development Platform Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI Drug Development Platform Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 AI Drug Development Platform Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World AI Drug Development Platform Consumption Value (2018-2029)
2.2 World AI Drug Development Platform Consumption Value by Region
2.2.1 World AI Drug Development Platform Consumption Value by Region (2018-2023)
2.2.2 World AI Drug Development Platform Consumption Value Forecast by Region (2024-2029)
2.3 United States AI Drug Development Platform Consumption Value (2018-2029)
2.4 China AI Drug Development Platform Consumption Value (2018-2029)
2.5 Europe AI Drug Development Platform Consumption Value (2018-2029)
2.6 Japan AI Drug Development Platform Consumption Value (2018-2029)
2.7 South Korea AI Drug Development Platform Consumption Value (2018-2029)
2.8 ASEAN AI Drug Development Platform Consumption Value (2018-2029)
2.9 India AI Drug Development Platform Consumption Value (2018-2029)
3 WORLD AI DRUG DEVELOPMENT PLATFORM COMPANIES COMPETITIVE ANALYSIS
3.1 World AI Drug Development Platform Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI Drug Development Platform Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI Drug Development Platform in 2022
3.2.3 Global Concentration Ratios (CR8) for AI Drug Development Platform in 2022
3.3 AI Drug Development Platform Company Evaluation Quadrant
3.4 AI Drug Development Platform Market: Overall Company Footprint Analysis
3.4.1 AI Drug Development Platform Market: Region Footprint
3.4.2 AI Drug Development Platform Market: Company Product Type Footprint
3.4.3 AI Drug Development Platform Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI Drug Development Platform Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI Drug Development Platform Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: AI Drug Development Platform Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: AI Drug Development Platform Consumption Value Comparison
4.2.1 United States VS China: AI Drug Development Platform Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: AI Drug Development Platform Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based AI Drug Development Platform Companies and Market Share, 2018-2023
4.3.1 United States Based AI Drug Development Platform Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI Drug Development Platform Revenue, (2018-2023)
4.4 China Based Companies AI Drug Development Platform Revenue and Market Share, 2018-2023
4.4.1 China Based AI Drug Development Platform Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI Drug Development Platform Revenue, (2018-2023)
4.5 Rest of World Based AI Drug Development Platform Companies and Market Share, 2018-2023
4.5.1 Rest of World Based AI Drug Development Platform Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies AI Drug Development Platform Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World AI Drug Development Platform Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Software Provider Mode
5.2.2 CRO Service Mode
5.2.3 Self-Development Pipeline Mode
5.3 Market Segment by Type
5.3.1 World AI Drug Development Platform Market Size by Type (2018-2023)
5.3.2 World AI Drug Development Platform Market Size by Type (2024-2029)
5.3.3 World AI Drug Development Platform Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World AI Drug Development Platform Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 SMEs
6.2.2 Large Enterprises
6.3 Market Segment by Application
6.3.1 World AI Drug Development Platform Market Size by Application (2018-2023)
6.3.2 World AI Drug Development Platform Market Size by Application (2024-2029)
6.3.3 World AI Drug Development Platform Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Insilico Medicine
7.1.1 Insilico Medicine Details
7.1.2 Insilico Medicine Major Business
7.1.3 Insilico Medicine AI Drug Development Platform Product and Services
7.1.4 Insilico Medicine AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Insilico Medicine Recent Developments/Updates
7.1.6 Insilico Medicine Competitive Strengths & Weaknesses
7.2 MindRank
7.2.1 MindRank Details
7.2.2 MindRank Major Business
7.2.3 MindRank AI Drug Development Platform Product and Services
7.2.4 MindRank AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 MindRank Recent Developments/Updates
7.2.6 MindRank Competitive Strengths & Weaknesses
7.3 BenevolentAI
7.3.1 BenevolentAI Details
7.3.2 BenevolentAI Major Business
7.3.3 BenevolentAI AI Drug Development Platform Product and Services
7.3.4 BenevolentAI AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 BenevolentAI Recent Developments/Updates
7.3.6 BenevolentAI Competitive Strengths & Weaknesses
7.4 Exscientia
7.4.1 Exscientia Details
7.4.2 Exscientia Major Business
7.4.3 Exscientia AI Drug Development Platform Product and Services
7.4.4 Exscientia AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Exscientia Recent Developments/Updates
7.4.6 Exscientia Competitive Strengths & Weaknesses
7.5 Deep Pharma Intelligence
7.5.1 Deep Pharma Intelligence Details
7.5.2 Deep Pharma Intelligence Major Business
7.5.3 Deep Pharma Intelligence AI Drug Development Platform Product and Services
7.5.4 Deep Pharma Intelligence AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Deep Pharma Intelligence Recent Developments/Updates
7.5.6 Deep Pharma Intelligence Competitive Strengths & Weaknesses
7.6 Delta4
7.6.1 Delta4 Details
7.6.2 Delta4 Major Business
7.6.3 Delta4 AI Drug Development Platform Product and Services
7.6.4 Delta4 AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Delta4 Recent Developments/Updates
7.6.6 Delta4 Competitive Strengths & Weaknesses
7.7 DNDi
7.7.1 DNDi Details
7.7.2 DNDi Major Business
7.7.3 DNDi AI Drug Development Platform Product and Services
7.7.4 DNDi AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 DNDi Recent Developments/Updates
7.7.6 DNDi Competitive Strengths & Weaknesses
7.8 Standigm
7.8.1 Standigm Details
7.8.2 Standigm Major Business
7.8.3 Standigm AI Drug Development Platform Product and Services
7.8.4 Standigm AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Standigm Recent Developments/Updates
7.8.6 Standigm Competitive Strengths & Weaknesses
7.9 Genesis Therapeutics
7.9.1 Genesis Therapeutics Details
7.9.2 Genesis Therapeutics Major Business
7.9.3 Genesis Therapeutics AI Drug Development Platform Product and Services
7.9.4 Genesis Therapeutics AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Genesis Therapeutics Recent Developments/Updates
7.9.6 Genesis Therapeutics Competitive Strengths & Weaknesses
7.10 Data2Discovery
7.10.1 Data2Discovery Details
7.10.2 Data2Discovery Major Business
7.10.3 Data2Discovery AI Drug Development Platform Product and Services
7.10.4 Data2Discovery AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Data2Discovery Recent Developments/Updates
7.10.6 Data2Discovery Competitive Strengths & Weaknesses
7.11 Unlearn.AI
7.11.1 Unlearn.AI Details
7.11.2 Unlearn.AI Major Business
7.11.3 Unlearn.AI AI Drug Development Platform Product and Services
7.11.4 Unlearn.AI AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Unlearn.AI Recent Developments/Updates
7.11.6 Unlearn.AI Competitive Strengths & Weaknesses
7.12 Deep Intelligent Pharma
7.12.1 Deep Intelligent Pharma Details
7.12.2 Deep Intelligent Pharma Major Business
7.12.3 Deep Intelligent Pharma AI Drug Development Platform Product and Services
7.12.4 Deep Intelligent Pharma AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Deep Intelligent Pharma Recent Developments/Updates
7.12.6 Deep Intelligent Pharma Competitive Strengths & Weaknesses
7.13 CarbonSilicon AI Technology
7.13.1 CarbonSilicon AI Technology Details
7.13.2 CarbonSilicon AI Technology Major Business
7.13.3 CarbonSilicon AI Technology AI Drug Development Platform Product and Services
7.13.4 CarbonSilicon AI Technology AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 CarbonSilicon AI Technology Recent Developments/Updates
7.13.6 CarbonSilicon AI Technology Competitive Strengths & Weaknesses
7.14 XtalPi
7.14.1 XtalPi Details
7.14.2 XtalPi Major Business
7.14.3 XtalPi AI Drug Development Platform Product and Services
7.14.4 XtalPi AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 XtalPi Recent Developments/Updates
7.14.6 XtalPi Competitive Strengths & Weaknesses
7.15 Tencent
7.15.1 Tencent Details
7.15.2 Tencent Major Business
7.15.3 Tencent AI Drug Development Platform Product and Services
7.15.4 Tencent AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Tencent Recent Developments/Updates
7.15.6 Tencent Competitive Strengths & Weaknesses
7.16 Fastone
7.16.1 Fastone Details
7.16.2 Fastone Major Business
7.16.3 Fastone AI Drug Development Platform Product and Services
7.16.4 Fastone AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Fastone Recent Developments/Updates
7.16.6 Fastone Competitive Strengths & Weaknesses
7.17 Stonewise
7.17.1 Stonewise Details
7.17.2 Stonewise Major Business
7.17.3 Stonewise AI Drug Development Platform Product and Services
7.17.4 Stonewise AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Stonewise Recent Developments/Updates
7.17.6 Stonewise Competitive Strengths & Weaknesses
7.18 HitGen
7.18.1 HitGen Details
7.18.2 HitGen Major Business
7.18.3 HitGen AI Drug Development Platform Product and Services
7.18.4 HitGen AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 HitGen Recent Developments/Updates
7.18.6 HitGen Competitive Strengths & Weaknesses
7.19 Galixir
7.19.1 Galixir Details
7.19.2 Galixir Major Business
7.19.3 Galixir AI Drug Development Platform Product and Services
7.19.4 Galixir AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Galixir Recent Developments/Updates
7.19.6 Galixir Competitive Strengths & Weaknesses
7.20 Matwings Technology
7.20.1 Matwings Technology Details
7.20.2 Matwings Technology Major Business
7.20.3 Matwings Technology AI Drug Development Platform Product and Services
7.20.4 Matwings Technology AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Matwings Technology Recent Developments/Updates
7.20.6 Matwings Technology Competitive Strengths & Weaknesses
7.21 Alibaba
7.21.1 Alibaba Details
7.21.2 Alibaba Major Business
7.21.3 Alibaba AI Drug Development Platform Product and Services
7.21.4 Alibaba AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Alibaba Recent Developments/Updates
7.21.6 Alibaba Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 AI Drug Development Platform Industry Chain
8.2 AI Drug Development Platform Upstream Analysis
8.3 AI Drug Development Platform Midstream Analysis
8.4 AI Drug Development Platform Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 AI Drug Development Platform Introduction
1.2 World AI Drug Development Platform Market Size & Forecast (2018 & 2022 & 2029)
1.3 World AI Drug Development Platform Total Market by Region (by Headquarter Location)
1.3.1 World AI Drug Development Platform Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States AI Drug Development Platform Market Size (2018-2029)
1.3.3 China AI Drug Development Platform Market Size (2018-2029)
1.3.4 Europe AI Drug Development Platform Market Size (2018-2029)
1.3.5 Japan AI Drug Development Platform Market Size (2018-2029)
1.3.6 South Korea AI Drug Development Platform Market Size (2018-2029)
1.3.7 ASEAN AI Drug Development Platform Market Size (2018-2029)
1.3.8 India AI Drug Development Platform Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI Drug Development Platform Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 AI Drug Development Platform Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World AI Drug Development Platform Consumption Value (2018-2029)
2.2 World AI Drug Development Platform Consumption Value by Region
2.2.1 World AI Drug Development Platform Consumption Value by Region (2018-2023)
2.2.2 World AI Drug Development Platform Consumption Value Forecast by Region (2024-2029)
2.3 United States AI Drug Development Platform Consumption Value (2018-2029)
2.4 China AI Drug Development Platform Consumption Value (2018-2029)
2.5 Europe AI Drug Development Platform Consumption Value (2018-2029)
2.6 Japan AI Drug Development Platform Consumption Value (2018-2029)
2.7 South Korea AI Drug Development Platform Consumption Value (2018-2029)
2.8 ASEAN AI Drug Development Platform Consumption Value (2018-2029)
2.9 India AI Drug Development Platform Consumption Value (2018-2029)
3 WORLD AI DRUG DEVELOPMENT PLATFORM COMPANIES COMPETITIVE ANALYSIS
3.1 World AI Drug Development Platform Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI Drug Development Platform Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI Drug Development Platform in 2022
3.2.3 Global Concentration Ratios (CR8) for AI Drug Development Platform in 2022
3.3 AI Drug Development Platform Company Evaluation Quadrant
3.4 AI Drug Development Platform Market: Overall Company Footprint Analysis
3.4.1 AI Drug Development Platform Market: Region Footprint
3.4.2 AI Drug Development Platform Market: Company Product Type Footprint
3.4.3 AI Drug Development Platform Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI Drug Development Platform Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI Drug Development Platform Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: AI Drug Development Platform Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: AI Drug Development Platform Consumption Value Comparison
4.2.1 United States VS China: AI Drug Development Platform Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: AI Drug Development Platform Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based AI Drug Development Platform Companies and Market Share, 2018-2023
4.3.1 United States Based AI Drug Development Platform Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI Drug Development Platform Revenue, (2018-2023)
4.4 China Based Companies AI Drug Development Platform Revenue and Market Share, 2018-2023
4.4.1 China Based AI Drug Development Platform Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI Drug Development Platform Revenue, (2018-2023)
4.5 Rest of World Based AI Drug Development Platform Companies and Market Share, 2018-2023
4.5.1 Rest of World Based AI Drug Development Platform Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies AI Drug Development Platform Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World AI Drug Development Platform Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Software Provider Mode
5.2.2 CRO Service Mode
5.2.3 Self-Development Pipeline Mode
5.3 Market Segment by Type
5.3.1 World AI Drug Development Platform Market Size by Type (2018-2023)
5.3.2 World AI Drug Development Platform Market Size by Type (2024-2029)
5.3.3 World AI Drug Development Platform Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World AI Drug Development Platform Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 SMEs
6.2.2 Large Enterprises
6.3 Market Segment by Application
6.3.1 World AI Drug Development Platform Market Size by Application (2018-2023)
6.3.2 World AI Drug Development Platform Market Size by Application (2024-2029)
6.3.3 World AI Drug Development Platform Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Insilico Medicine
7.1.1 Insilico Medicine Details
7.1.2 Insilico Medicine Major Business
7.1.3 Insilico Medicine AI Drug Development Platform Product and Services
7.1.4 Insilico Medicine AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Insilico Medicine Recent Developments/Updates
7.1.6 Insilico Medicine Competitive Strengths & Weaknesses
7.2 MindRank
7.2.1 MindRank Details
7.2.2 MindRank Major Business
7.2.3 MindRank AI Drug Development Platform Product and Services
7.2.4 MindRank AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 MindRank Recent Developments/Updates
7.2.6 MindRank Competitive Strengths & Weaknesses
7.3 BenevolentAI
7.3.1 BenevolentAI Details
7.3.2 BenevolentAI Major Business
7.3.3 BenevolentAI AI Drug Development Platform Product and Services
7.3.4 BenevolentAI AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 BenevolentAI Recent Developments/Updates
7.3.6 BenevolentAI Competitive Strengths & Weaknesses
7.4 Exscientia
7.4.1 Exscientia Details
7.4.2 Exscientia Major Business
7.4.3 Exscientia AI Drug Development Platform Product and Services
7.4.4 Exscientia AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Exscientia Recent Developments/Updates
7.4.6 Exscientia Competitive Strengths & Weaknesses
7.5 Deep Pharma Intelligence
7.5.1 Deep Pharma Intelligence Details
7.5.2 Deep Pharma Intelligence Major Business
7.5.3 Deep Pharma Intelligence AI Drug Development Platform Product and Services
7.5.4 Deep Pharma Intelligence AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Deep Pharma Intelligence Recent Developments/Updates
7.5.6 Deep Pharma Intelligence Competitive Strengths & Weaknesses
7.6 Delta4
7.6.1 Delta4 Details
7.6.2 Delta4 Major Business
7.6.3 Delta4 AI Drug Development Platform Product and Services
7.6.4 Delta4 AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Delta4 Recent Developments/Updates
7.6.6 Delta4 Competitive Strengths & Weaknesses
7.7 DNDi
7.7.1 DNDi Details
7.7.2 DNDi Major Business
7.7.3 DNDi AI Drug Development Platform Product and Services
7.7.4 DNDi AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 DNDi Recent Developments/Updates
7.7.6 DNDi Competitive Strengths & Weaknesses
7.8 Standigm
7.8.1 Standigm Details
7.8.2 Standigm Major Business
7.8.3 Standigm AI Drug Development Platform Product and Services
7.8.4 Standigm AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Standigm Recent Developments/Updates
7.8.6 Standigm Competitive Strengths & Weaknesses
7.9 Genesis Therapeutics
7.9.1 Genesis Therapeutics Details
7.9.2 Genesis Therapeutics Major Business
7.9.3 Genesis Therapeutics AI Drug Development Platform Product and Services
7.9.4 Genesis Therapeutics AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Genesis Therapeutics Recent Developments/Updates
7.9.6 Genesis Therapeutics Competitive Strengths & Weaknesses
7.10 Data2Discovery
7.10.1 Data2Discovery Details
7.10.2 Data2Discovery Major Business
7.10.3 Data2Discovery AI Drug Development Platform Product and Services
7.10.4 Data2Discovery AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Data2Discovery Recent Developments/Updates
7.10.6 Data2Discovery Competitive Strengths & Weaknesses
7.11 Unlearn.AI
7.11.1 Unlearn.AI Details
7.11.2 Unlearn.AI Major Business
7.11.3 Unlearn.AI AI Drug Development Platform Product and Services
7.11.4 Unlearn.AI AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Unlearn.AI Recent Developments/Updates
7.11.6 Unlearn.AI Competitive Strengths & Weaknesses
7.12 Deep Intelligent Pharma
7.12.1 Deep Intelligent Pharma Details
7.12.2 Deep Intelligent Pharma Major Business
7.12.3 Deep Intelligent Pharma AI Drug Development Platform Product and Services
7.12.4 Deep Intelligent Pharma AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Deep Intelligent Pharma Recent Developments/Updates
7.12.6 Deep Intelligent Pharma Competitive Strengths & Weaknesses
7.13 CarbonSilicon AI Technology
7.13.1 CarbonSilicon AI Technology Details
7.13.2 CarbonSilicon AI Technology Major Business
7.13.3 CarbonSilicon AI Technology AI Drug Development Platform Product and Services
7.13.4 CarbonSilicon AI Technology AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 CarbonSilicon AI Technology Recent Developments/Updates
7.13.6 CarbonSilicon AI Technology Competitive Strengths & Weaknesses
7.14 XtalPi
7.14.1 XtalPi Details
7.14.2 XtalPi Major Business
7.14.3 XtalPi AI Drug Development Platform Product and Services
7.14.4 XtalPi AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 XtalPi Recent Developments/Updates
7.14.6 XtalPi Competitive Strengths & Weaknesses
7.15 Tencent
7.15.1 Tencent Details
7.15.2 Tencent Major Business
7.15.3 Tencent AI Drug Development Platform Product and Services
7.15.4 Tencent AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Tencent Recent Developments/Updates
7.15.6 Tencent Competitive Strengths & Weaknesses
7.16 Fastone
7.16.1 Fastone Details
7.16.2 Fastone Major Business
7.16.3 Fastone AI Drug Development Platform Product and Services
7.16.4 Fastone AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Fastone Recent Developments/Updates
7.16.6 Fastone Competitive Strengths & Weaknesses
7.17 Stonewise
7.17.1 Stonewise Details
7.17.2 Stonewise Major Business
7.17.3 Stonewise AI Drug Development Platform Product and Services
7.17.4 Stonewise AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Stonewise Recent Developments/Updates
7.17.6 Stonewise Competitive Strengths & Weaknesses
7.18 HitGen
7.18.1 HitGen Details
7.18.2 HitGen Major Business
7.18.3 HitGen AI Drug Development Platform Product and Services
7.18.4 HitGen AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 HitGen Recent Developments/Updates
7.18.6 HitGen Competitive Strengths & Weaknesses
7.19 Galixir
7.19.1 Galixir Details
7.19.2 Galixir Major Business
7.19.3 Galixir AI Drug Development Platform Product and Services
7.19.4 Galixir AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Galixir Recent Developments/Updates
7.19.6 Galixir Competitive Strengths & Weaknesses
7.20 Matwings Technology
7.20.1 Matwings Technology Details
7.20.2 Matwings Technology Major Business
7.20.3 Matwings Technology AI Drug Development Platform Product and Services
7.20.4 Matwings Technology AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Matwings Technology Recent Developments/Updates
7.20.6 Matwings Technology Competitive Strengths & Weaknesses
7.21 Alibaba
7.21.1 Alibaba Details
7.21.2 Alibaba Major Business
7.21.3 Alibaba AI Drug Development Platform Product and Services
7.21.4 Alibaba AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Alibaba Recent Developments/Updates
7.21.6 Alibaba Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 AI Drug Development Platform Industry Chain
8.2 AI Drug Development Platform Upstream Analysis
8.3 AI Drug Development Platform Midstream Analysis
8.4 AI Drug Development Platform Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World AI Drug Development Platform Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World AI Drug Development Platform Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World AI Drug Development Platform Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World AI Drug Development Platform Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World AI Drug Development Platform Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI Drug Development Platform Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World AI Drug Development Platform Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World AI Drug Development Platform Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World AI Drug Development Platform Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key AI Drug Development Platform Players in 2022
Table 12. World AI Drug Development Platform Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global AI Drug Development Platform Company Evaluation Quadrant
Table 14. Head Office of Key AI Drug Development Platform Player
Table 15. AI Drug Development Platform Market: Company Product Type Footprint
Table 16. AI Drug Development Platform Market: Company Product Application Footprint
Table 17. AI Drug Development Platform Mergers & Acquisitions Activity
Table 18. United States VS China AI Drug Development Platform Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China AI Drug Development Platform Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based AI Drug Development Platform Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI Drug Development Platform Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies AI Drug Development Platform Revenue Market Share (2018-2023)
Table 23. China Based AI Drug Development Platform Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI Drug Development Platform Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies AI Drug Development Platform Revenue Market Share (2018-2023)
Table 26. Rest of World Based AI Drug Development Platform Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies AI Drug Development Platform Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies AI Drug Development Platform Revenue Market Share (2018-2023)
Table 29. World AI Drug Development Platform Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World AI Drug Development Platform Market Size by Type (2018-2023) & (USD Million)
Table 31. World AI Drug Development Platform Market Size by Type (2024-2029) & (USD Million)
Table 32. World AI Drug Development Platform Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World AI Drug Development Platform Market Size by Application (2018-2023) & (USD Million)
Table 34. World AI Drug Development Platform Market Size by Application (2024-2029) & (USD Million)
Table 35. Insilico Medicine Basic Information, Area Served and Competitors
Table 36. Insilico Medicine Major Business
Table 37. Insilico Medicine AI Drug Development Platform Product and Services
Table 38. Insilico Medicine AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Insilico Medicine Recent Developments/Updates
Table 40. Insilico Medicine Competitive Strengths & Weaknesses
Table 41. MindRank Basic Information, Area Served and Competitors
Table 42. MindRank Major Business
Table 43. MindRank AI Drug Development Platform Product and Services
Table 44. MindRank AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. MindRank Recent Developments/Updates
Table 46. MindRank Competitive Strengths & Weaknesses
Table 47. BenevolentAI Basic Information, Area Served and Competitors
Table 48. BenevolentAI Major Business
Table 49. BenevolentAI AI Drug Development Platform Product and Services
Table 50. BenevolentAI AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. BenevolentAI Recent Developments/Updates
Table 52. BenevolentAI Competitive Strengths & Weaknesses
Table 53. Exscientia Basic Information, Area Served and Competitors
Table 54. Exscientia Major Business
Table 55. Exscientia AI Drug Development Platform Product and Services
Table 56. Exscientia AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Exscientia Recent Developments/Updates
Table 58. Exscientia Competitive Strengths & Weaknesses
Table 59. Deep Pharma Intelligence Basic Information, Area Served and Competitors
Table 60. Deep Pharma Intelligence Major Business
Table 61. Deep Pharma Intelligence AI Drug Development Platform Product and Services
Table 62. Deep Pharma Intelligence AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Deep Pharma Intelligence Recent Developments/Updates
Table 64. Deep Pharma Intelligence Competitive Strengths & Weaknesses
Table 65. Delta4 Basic Information, Area Served and Competitors
Table 66. Delta4 Major Business
Table 67. Delta4 AI Drug Development Platform Product and Services
Table 68. Delta4 AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Delta4 Recent Developments/Updates
Table 70. Delta4 Competitive Strengths & Weaknesses
Table 71. DNDi Basic Information, Area Served and Competitors
Table 72. DNDi Major Business
Table 73. DNDi AI Drug Development Platform Product and Services
Table 74. DNDi AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. DNDi Recent Developments/Updates
Table 76. DNDi Competitive Strengths & Weaknesses
Table 77. Standigm Basic Information, Area Served and Competitors
Table 78. Standigm Major Business
Table 79. Standigm AI Drug Development Platform Product and Services
Table 80. Standigm AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Standigm Recent Developments/Updates
Table 82. Standigm Competitive Strengths & Weaknesses
Table 83. Genesis Therapeutics Basic Information, Area Served and Competitors
Table 84. Genesis Therapeutics Major Business
Table 85. Genesis Therapeutics AI Drug Development Platform Product and Services
Table 86. Genesis Therapeutics AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Genesis Therapeutics Recent Developments/Updates
Table 88. Genesis Therapeutics Competitive Strengths & Weaknesses
Table 89. Data2Discovery Basic Information, Area Served and Competitors
Table 90. Data2Discovery Major Business
Table 91. Data2Discovery AI Drug Development Platform Product and Services
Table 92. Data2Discovery AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Data2Discovery Recent Developments/Updates
Table 94. Data2Discovery Competitive Strengths & Weaknesses
Table 95. Unlearn.AI Basic Information, Area Served and Competitors
Table 96. Unlearn.AI Major Business
Table 97. Unlearn.AI AI Drug Development Platform Product and Services
Table 98. Unlearn.AI AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Unlearn.AI Recent Developments/Updates
Table 100. Unlearn.AI Competitive Strengths & Weaknesses
Table 101. Deep Intelligent Pharma Basic Information, Area Served and Competitors
Table 102. Deep Intelligent Pharma Major Business
Table 103. Deep Intelligent Pharma AI Drug Development Platform Product and Services
Table 104. Deep Intelligent Pharma AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Deep Intelligent Pharma Recent Developments/Updates
Table 106. Deep Intelligent Pharma Competitive Strengths & Weaknesses
Table 107. CarbonSilicon AI Technology Basic Information, Area Served and Competitors
Table 108. CarbonSilicon AI Technology Major Business
Table 109. CarbonSilicon AI Technology AI Drug Development Platform Product and Services
Table 110. CarbonSilicon AI Technology AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. CarbonSilicon AI Technology Recent Developments/Updates
Table 112. CarbonSilicon AI Technology Competitive Strengths & Weaknesses
Table 113. XtalPi Basic Information, Area Served and Competitors
Table 114. XtalPi Major Business
Table 115. XtalPi AI Drug Development Platform Product and Services
Table 116. XtalPi AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. XtalPi Recent Developments/Updates
Table 118. XtalPi Competitive Strengths & Weaknesses
Table 119. Tencent Basic Information, Area Served and Competitors
Table 120. Tencent Major Business
Table 121. Tencent AI Drug Development Platform Product and Services
Table 122. Tencent AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Tencent Recent Developments/Updates
Table 124. Tencent Competitive Strengths & Weaknesses
Table 125. Fastone Basic Information, Area Served and Competitors
Table 126. Fastone Major Business
Table 127. Fastone AI Drug Development Platform Product and Services
Table 128. Fastone AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Fastone Recent Developments/Updates
Table 130. Fastone Competitive Strengths & Weaknesses
Table 131. Stonewise Basic Information, Area Served and Competitors
Table 132. Stonewise Major Business
Table 133. Stonewise AI Drug Development Platform Product and Services
Table 134. Stonewise AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Stonewise Recent Developments/Updates
Table 136. Stonewise Competitive Strengths & Weaknesses
Table 137. HitGen Basic Information, Area Served and Competitors
Table 138. HitGen Major Business
Table 139. HitGen AI Drug Development Platform Product and Services
Table 140. HitGen AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. HitGen Recent Developments/Updates
Table 142. HitGen Competitive Strengths & Weaknesses
Table 143. Galixir Basic Information, Area Served and Competitors
Table 144. Galixir Major Business
Table 145. Galixir AI Drug Development Platform Product and Services
Table 146. Galixir AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Galixir Recent Developments/Updates
Table 148. Galixir Competitive Strengths & Weaknesses
Table 149. Matwings Technology Basic Information, Area Served and Competitors
Table 150. Matwings Technology Major Business
Table 151. Matwings Technology AI Drug Development Platform Product and Services
Table 152. Matwings Technology AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. Matwings Technology Recent Developments/Updates
Table 154. Alibaba Basic Information, Area Served and Competitors
Table 155. Alibaba Major Business
Table 156. Alibaba AI Drug Development Platform Product and Services
Table 157. Alibaba AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 158. Global Key Players of AI Drug Development Platform Upstream (Raw Materials)
Table 159. AI Drug Development Platform Typical Customers
Table 1. World AI Drug Development Platform Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World AI Drug Development Platform Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World AI Drug Development Platform Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World AI Drug Development Platform Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World AI Drug Development Platform Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI Drug Development Platform Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World AI Drug Development Platform Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World AI Drug Development Platform Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World AI Drug Development Platform Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key AI Drug Development Platform Players in 2022
Table 12. World AI Drug Development Platform Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global AI Drug Development Platform Company Evaluation Quadrant
Table 14. Head Office of Key AI Drug Development Platform Player
Table 15. AI Drug Development Platform Market: Company Product Type Footprint
Table 16. AI Drug Development Platform Market: Company Product Application Footprint
Table 17. AI Drug Development Platform Mergers & Acquisitions Activity
Table 18. United States VS China AI Drug Development Platform Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China AI Drug Development Platform Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based AI Drug Development Platform Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI Drug Development Platform Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies AI Drug Development Platform Revenue Market Share (2018-2023)
Table 23. China Based AI Drug Development Platform Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI Drug Development Platform Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies AI Drug Development Platform Revenue Market Share (2018-2023)
Table 26. Rest of World Based AI Drug Development Platform Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies AI Drug Development Platform Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies AI Drug Development Platform Revenue Market Share (2018-2023)
Table 29. World AI Drug Development Platform Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World AI Drug Development Platform Market Size by Type (2018-2023) & (USD Million)
Table 31. World AI Drug Development Platform Market Size by Type (2024-2029) & (USD Million)
Table 32. World AI Drug Development Platform Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World AI Drug Development Platform Market Size by Application (2018-2023) & (USD Million)
Table 34. World AI Drug Development Platform Market Size by Application (2024-2029) & (USD Million)
Table 35. Insilico Medicine Basic Information, Area Served and Competitors
Table 36. Insilico Medicine Major Business
Table 37. Insilico Medicine AI Drug Development Platform Product and Services
Table 38. Insilico Medicine AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Insilico Medicine Recent Developments/Updates
Table 40. Insilico Medicine Competitive Strengths & Weaknesses
Table 41. MindRank Basic Information, Area Served and Competitors
Table 42. MindRank Major Business
Table 43. MindRank AI Drug Development Platform Product and Services
Table 44. MindRank AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. MindRank Recent Developments/Updates
Table 46. MindRank Competitive Strengths & Weaknesses
Table 47. BenevolentAI Basic Information, Area Served and Competitors
Table 48. BenevolentAI Major Business
Table 49. BenevolentAI AI Drug Development Platform Product and Services
Table 50. BenevolentAI AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. BenevolentAI Recent Developments/Updates
Table 52. BenevolentAI Competitive Strengths & Weaknesses
Table 53. Exscientia Basic Information, Area Served and Competitors
Table 54. Exscientia Major Business
Table 55. Exscientia AI Drug Development Platform Product and Services
Table 56. Exscientia AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Exscientia Recent Developments/Updates
Table 58. Exscientia Competitive Strengths & Weaknesses
Table 59. Deep Pharma Intelligence Basic Information, Area Served and Competitors
Table 60. Deep Pharma Intelligence Major Business
Table 61. Deep Pharma Intelligence AI Drug Development Platform Product and Services
Table 62. Deep Pharma Intelligence AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Deep Pharma Intelligence Recent Developments/Updates
Table 64. Deep Pharma Intelligence Competitive Strengths & Weaknesses
Table 65. Delta4 Basic Information, Area Served and Competitors
Table 66. Delta4 Major Business
Table 67. Delta4 AI Drug Development Platform Product and Services
Table 68. Delta4 AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Delta4 Recent Developments/Updates
Table 70. Delta4 Competitive Strengths & Weaknesses
Table 71. DNDi Basic Information, Area Served and Competitors
Table 72. DNDi Major Business
Table 73. DNDi AI Drug Development Platform Product and Services
Table 74. DNDi AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. DNDi Recent Developments/Updates
Table 76. DNDi Competitive Strengths & Weaknesses
Table 77. Standigm Basic Information, Area Served and Competitors
Table 78. Standigm Major Business
Table 79. Standigm AI Drug Development Platform Product and Services
Table 80. Standigm AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Standigm Recent Developments/Updates
Table 82. Standigm Competitive Strengths & Weaknesses
Table 83. Genesis Therapeutics Basic Information, Area Served and Competitors
Table 84. Genesis Therapeutics Major Business
Table 85. Genesis Therapeutics AI Drug Development Platform Product and Services
Table 86. Genesis Therapeutics AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Genesis Therapeutics Recent Developments/Updates
Table 88. Genesis Therapeutics Competitive Strengths & Weaknesses
Table 89. Data2Discovery Basic Information, Area Served and Competitors
Table 90. Data2Discovery Major Business
Table 91. Data2Discovery AI Drug Development Platform Product and Services
Table 92. Data2Discovery AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Data2Discovery Recent Developments/Updates
Table 94. Data2Discovery Competitive Strengths & Weaknesses
Table 95. Unlearn.AI Basic Information, Area Served and Competitors
Table 96. Unlearn.AI Major Business
Table 97. Unlearn.AI AI Drug Development Platform Product and Services
Table 98. Unlearn.AI AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Unlearn.AI Recent Developments/Updates
Table 100. Unlearn.AI Competitive Strengths & Weaknesses
Table 101. Deep Intelligent Pharma Basic Information, Area Served and Competitors
Table 102. Deep Intelligent Pharma Major Business
Table 103. Deep Intelligent Pharma AI Drug Development Platform Product and Services
Table 104. Deep Intelligent Pharma AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Deep Intelligent Pharma Recent Developments/Updates
Table 106. Deep Intelligent Pharma Competitive Strengths & Weaknesses
Table 107. CarbonSilicon AI Technology Basic Information, Area Served and Competitors
Table 108. CarbonSilicon AI Technology Major Business
Table 109. CarbonSilicon AI Technology AI Drug Development Platform Product and Services
Table 110. CarbonSilicon AI Technology AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. CarbonSilicon AI Technology Recent Developments/Updates
Table 112. CarbonSilicon AI Technology Competitive Strengths & Weaknesses
Table 113. XtalPi Basic Information, Area Served and Competitors
Table 114. XtalPi Major Business
Table 115. XtalPi AI Drug Development Platform Product and Services
Table 116. XtalPi AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. XtalPi Recent Developments/Updates
Table 118. XtalPi Competitive Strengths & Weaknesses
Table 119. Tencent Basic Information, Area Served and Competitors
Table 120. Tencent Major Business
Table 121. Tencent AI Drug Development Platform Product and Services
Table 122. Tencent AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Tencent Recent Developments/Updates
Table 124. Tencent Competitive Strengths & Weaknesses
Table 125. Fastone Basic Information, Area Served and Competitors
Table 126. Fastone Major Business
Table 127. Fastone AI Drug Development Platform Product and Services
Table 128. Fastone AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Fastone Recent Developments/Updates
Table 130. Fastone Competitive Strengths & Weaknesses
Table 131. Stonewise Basic Information, Area Served and Competitors
Table 132. Stonewise Major Business
Table 133. Stonewise AI Drug Development Platform Product and Services
Table 134. Stonewise AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Stonewise Recent Developments/Updates
Table 136. Stonewise Competitive Strengths & Weaknesses
Table 137. HitGen Basic Information, Area Served and Competitors
Table 138. HitGen Major Business
Table 139. HitGen AI Drug Development Platform Product and Services
Table 140. HitGen AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. HitGen Recent Developments/Updates
Table 142. HitGen Competitive Strengths & Weaknesses
Table 143. Galixir Basic Information, Area Served and Competitors
Table 144. Galixir Major Business
Table 145. Galixir AI Drug Development Platform Product and Services
Table 146. Galixir AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Galixir Recent Developments/Updates
Table 148. Galixir Competitive Strengths & Weaknesses
Table 149. Matwings Technology Basic Information, Area Served and Competitors
Table 150. Matwings Technology Major Business
Table 151. Matwings Technology AI Drug Development Platform Product and Services
Table 152. Matwings Technology AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. Matwings Technology Recent Developments/Updates
Table 154. Alibaba Basic Information, Area Served and Competitors
Table 155. Alibaba Major Business
Table 156. Alibaba AI Drug Development Platform Product and Services
Table 157. Alibaba AI Drug Development Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 158. Global Key Players of AI Drug Development Platform Upstream (Raw Materials)
Table 159. AI Drug Development Platform Typical Customers
LIST OF FIGURES
Figure 1. AI Drug Development Platform Picture
Figure 2. World AI Drug Development Platform Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World AI Drug Development Platform Total Market Size (2018-2029) & (USD Million)
Figure 4. World AI Drug Development Platform Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World AI Drug Development Platform Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company AI Drug Development Platform Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company AI Drug Development Platform Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company AI Drug Development Platform Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company AI Drug Development Platform Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company AI Drug Development Platform Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company AI Drug Development Platform Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company AI Drug Development Platform Revenue (2018-2029) & (USD Million)
Figure 13. AI Drug Development Platform Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI Drug Development Platform Consumption Value (2018-2029) & (USD Million)
Figure 16. World AI Drug Development Platform Consumption Value Market Share by Region (2018-2029)
Figure 17. United States AI Drug Development Platform Consumption Value (2018-2029) & (USD Million)
Figure 18. China AI Drug Development Platform Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe AI Drug Development Platform Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan AI Drug Development Platform Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea AI Drug Development Platform Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN AI Drug Development Platform Consumption Value (2018-2029) & (USD Million)
Figure 23. India AI Drug Development Platform Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of AI Drug Development Platform by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI Drug Development Platform Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI Drug Development Platform Markets in 2022
Figure 27. United States VS China: AI Drug Development Platform Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: AI Drug Development Platform Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World AI Drug Development Platform Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World AI Drug Development Platform Market Size Market Share by Type in 2022
Figure 31. Software Provider Mode
Figure 32. CRO Service Mode
Figure 33. Self-Development Pipeline Mode
Figure 34. World AI Drug Development Platform Market Size Market Share by Type (2018-2029)
Figure 35. World AI Drug Development Platform Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World AI Drug Development Platform Market Size Market Share by Application in 2022
Figure 37. SMEs
Figure 38. Large Enterprises
Figure 39. AI Drug Development Platform Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Figure 1. AI Drug Development Platform Picture
Figure 2. World AI Drug Development Platform Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World AI Drug Development Platform Total Market Size (2018-2029) & (USD Million)
Figure 4. World AI Drug Development Platform Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World AI Drug Development Platform Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company AI Drug Development Platform Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company AI Drug Development Platform Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company AI Drug Development Platform Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company AI Drug Development Platform Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company AI Drug Development Platform Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company AI Drug Development Platform Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company AI Drug Development Platform Revenue (2018-2029) & (USD Million)
Figure 13. AI Drug Development Platform Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI Drug Development Platform Consumption Value (2018-2029) & (USD Million)
Figure 16. World AI Drug Development Platform Consumption Value Market Share by Region (2018-2029)
Figure 17. United States AI Drug Development Platform Consumption Value (2018-2029) & (USD Million)
Figure 18. China AI Drug Development Platform Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe AI Drug Development Platform Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan AI Drug Development Platform Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea AI Drug Development Platform Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN AI Drug Development Platform Consumption Value (2018-2029) & (USD Million)
Figure 23. India AI Drug Development Platform Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of AI Drug Development Platform by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI Drug Development Platform Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI Drug Development Platform Markets in 2022
Figure 27. United States VS China: AI Drug Development Platform Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: AI Drug Development Platform Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World AI Drug Development Platform Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World AI Drug Development Platform Market Size Market Share by Type in 2022
Figure 31. Software Provider Mode
Figure 32. CRO Service Mode
Figure 33. Self-Development Pipeline Mode
Figure 34. World AI Drug Development Platform Market Size Market Share by Type (2018-2029)
Figure 35. World AI Drug Development Platform Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World AI Drug Development Platform Market Size Market Share by Application in 2022
Figure 37. SMEs
Figure 38. Large Enterprises
Figure 39. AI Drug Development Platform Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
